What is the incidence of Herpes Simplex Virus type 1 (HSV1) causing genital herpes?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

HSV-1 as a Cause of Genital Herpes: Increasing Incidence

HSV-1 now accounts for a substantial and increasing proportion of genital herpes cases, particularly in young adults, with some populations showing HSV-1 causing 50-70% of new genital herpes infections in individuals under 30 years of age. 1, 2

Epidemiological Trends

The landscape of genital herpes has shifted dramatically over the past two decades:

  • In young women ≤30 years old, HSV-1 causes approximately 70% of genital herpes cases, representing a marked departure from historical patterns where HSV-2 predominated 2
  • In young men of the same age range, HSV-1 accounts for approximately 45% of genital herpes isolates 2
  • The proportion of HSV-1 genital infections declines sharply with age, dropping from 73.7% in women under 31 years to only 4.5% in women over 60 years 2
  • Overall population data shows HSV-1 seroprevalence of 47.8% in US adults aged 14-49 years (2015-2016), though this reflects both oral and genital infection 1

Mechanism Behind the Shift

The increasing incidence of HSV-1 genital herpes stems from specific behavioral and immunological factors:

  • Changing sexual practices, particularly increased oro-genital contact, directly transmit HSV-1 from oral sites to genital mucosa 3, 4
  • Declining childhood HSV-1 acquisition means more young adults remain HSV-1 seronegative and susceptible to genital infection during sexual debut 5
  • Condom use during intercourse (but not during oral sex) may paradoxically increase the relative proportion of HSV-1 genital infections by preventing HSV-2 transmission while allowing oral-genital HSV-1 transmission 4

Critical Clinical Distinctions

Understanding the differences between HSV-1 and HSV-2 genital infections is essential for patient counseling:

  • Genital HSV-1 recurs significantly less frequently than HSV-2, with a recurrence rate of 1.3 episodes/year in the first year, declining to 0.7 episodes/year in the second year 6
  • 43% of patients with primary genital HSV-1 experience no recurrences in the first year, and 67% have no recurrences in the second year 6
  • The initial clinical presentation of genital HSV-1 is indistinguishable from HSV-2, making laboratory typing essential for accurate prognosis 3
  • Genital HSV-1 has less viral shedding and fewer recurrences compared to HSV-2, particularly after the first year 7

Diagnostic Implications

The rising incidence of HSV-1 genital herpes necessitates specific diagnostic approaches:

  • Viral typing should be performed on all genital herpes isolates because the natural history and recurrence patterns differ substantially between HSV-1 and HSV-2 3, 6
  • Type-specific serologic testing can distinguish HSV-1 from HSV-2 antibodies and is useful for diagnosing unrecognized infections 3
  • Among HSV-1 seropositive individuals without HSV-2,1.8% report diagnosed genital herpes, suggesting increasing genital HSV-1 transmission 5

Common Pitfalls

  • Do not assume all genital herpes is HSV-2—this assumption leads to inaccurate prognostic counseling, particularly in young adults 2
  • Do not prescribe long-term suppressive therapy for genital HSV-1 without considering the low recurrence rate—suppressive therapy for genital HSV-1 has not been shown to reduce transmission to sexual partners 7
  • Do not overlook the psychological impact of misdiagnosis—patients with genital HSV-1 have a significantly better prognosis than those with HSV-2, and accurate typing reduces unnecessary anxiety 6

Public Health Context

  • Most genital herpes infections (80-90%) progress subclinically, yet transmission occurs during asymptomatic viral shedding 3
  • The stigma associated with HSV-2 is greater than HSV-1 because HSV-2 is almost exclusively sexually transmitted, while HSV-1 can be acquired through non-sexual contact 3
  • HSV-2 vaccines may have limited impact on overall genital herpes prevalence given the substantial and growing contribution of HSV-1 to genital disease burden 2

References

Guideline

Herpes Simplex Virus Epidemiology and Characteristics

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Predominance of herpes simplex virus type 1 from patients with genital herpes in Nova Scotia.

The Canadian journal of infectious diseases = Journal canadien des maladies infectieuses, 2003

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

HPV and Genital Herpes Prevention and Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.